フリードライヒ運動失調症(Friedreich Ataxia):世界の治験レビュー(2015年上半期版)...市場調査レポートについてご紹介

【英文タイトル】Friedreich Ataxia Global Clinical Trials Review, H1, 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Friedreich Ataxia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Friedreich Ataxia to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Friedreich Ataxia 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Friedreich Ataxia Therapeutics Clinical Trials 25
Prominent Drugs 27
Latest Clinical Trials News on Friedreich Ataxia 28
Jan 29, 2015: Reata Enrolls First Patient in the MOXIe Study, a Phase 2/3 Study Examining RTA 408 in Friedreich’s Ataxia Patients 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Santhera Pharmaceuticals Holding AG 29
Clinical Trial Overview of Santhera Pharmaceuticals Holding AG 29
Edison Pharmaceuticals, Inc. 30
Clinical Trial Overview of Edison Pharmaceuticals, Inc. 30
ApoPharma Inc. 31
Clinical Trial Overview of ApoPharma Inc. 31
ApoPharma 32
Clinical Trial Overview of ApoPharma 32
AAVLife 33
Clinical Trial Overview of AAVLife 33
Ipsen S.A. 34
Clinical Trial Overview of Ipsen S.A. 34
Horizon Pharma plc 35
Clinical Trial Overview of Horizon Pharma plc 35
H. Lundbeck A/S 36
Clinical Trial Overview of H. Lundbeck A/S 36
Apotex, Inc. 37
Clinical Trial Overview of Apotex, Inc. 37
Clinical Trial Overview of Top Institutes / Government 38
University of South Florida 38
Clinical Trial Overview of University of South Florida 38
National Institute of Neurological Disorders and Stroke 39
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 39
Assistance Publique – Hopitaux de Paris 40
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 40
Innsbruck Medical University 41
Clinical Trial Overview of Innsbruck Medical University 41
Federico II University 42
Clinical Trial Overview of Federico II University 42
Fundacion Para La Investigacion Biomedica Del Hospital Universitarios La Paz 43
Clinical Trial Overview of Fundacion Para La Investigacion Biomedica Del Hospital Universitarios La Paz 43
Royal Free London NHS Foundation Trust 44
Clinical Trial Overview of Royal Free London NHS Foundation Trust 44
Istittuto Nazionale Neurologico Carlo Besta 45
Clinical Trial Overview of Istittuto Nazionale Neurologico Carlo Besta 45
Erasme University Hospital 46
Clinical Trial Overview of Erasme University Hospital 46
The Children’s Hospital of Philadelphia 47
Clinical Trial Overview of The Children’s Hospital of Philadelphia 47
Five Key Clinical Profiles 48
Appendix 70
Abbreviations 70
Definitions 70
Research Methodology 71
Secondary Research 71
About GlobalData 72
Contact Us 72
Disclaimer 72
Source 72


【レポート販売概要】

■ タイトル:フリードライヒ運動失調症(Friedreich Ataxia):世界の治験レビュー(2015年上半期版)
■ 英文:Friedreich Ataxia Global Clinical Trials Review, H1, 2015
■ 発行日:2015年2月18日
■ 調査会社:GlobalData
■ 商品コード:GDHC2568CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。